MS
Insider
Mary T Szela
DirectorMary T Szela (Director) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in TriSalus Life Sciences, Inc. (TLSI). Across 3 priced purchase filings, the average 21-session return was +0.6% from execution and -1.4% from disclosure (delay-adjusted; derived). The largest single filing was $149K of ABSI (12,900 sh × $11.54, as filed), executed Jun 30.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+0.6%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-1.4%
same 3 filings, from disclosure
Filings, ttm
3
3 buys · 0 sells · 1 late
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$377K
shares × price, as filed
Last traded
Jun 30
Filed Jul 6
Median ADV $40.6M across their filed names
Open performance→Volume by month
Buys $377K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TLSIRecent filings
ABSIPURCHASE
Absci Corporation
View filing →
$149K12,900 sh × $11.54
Exec Jun 30
Filed Jul 6 · 4:06 PM ET † TLSIPURCHASE TriSalus Life Sciences, Inc. View filing → $103K
39,682 sh × $2.59
Exec May 15
Filed May 18 · 4:42 PM ET TLSIPURCHASE TriSalus Life Sciences, Inc. View filing → $125K
30,487 sh × $4.10
Exec Feb 23
Filed Feb 23 · 4:08 PM ET